Who owns BOLT BIOTHERAPEUTICS INC?
- Ticker: BOLT
- CUSIP Number: 097702203
Tip: Access positions for across all investors
Analyze quarterly positions in Bolt Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Bolt Biotherapeutics stock
Who bought or sold BOLT BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sofinnova Ventures | 138k | $530k | 0% | Jun 2026 |
|
| Renaissance Technologies | 99k | $380k | 28% | Jun 2026 |
|
| Vivo Capital | 72k | $279k | 0% | Jun 2026 |
|
| Citadel Advisors | 57k | $219k | 463% | Jun 2026 |
|
| T3 Companies | 38k | $146k | 0% | Jun 2026 |
|
| Board of Trustees of The Leland Stanford Junior University | 36k | $139k | 0% | Jun 2026 |
|
| Pfizer | 31k | $134k | 0% | Jun 2026 |
|
| Lynx1 Capital Management | 31k | $119k | 0% | Jun 2026 |
|
| Nano Cap New Millennium Growth Fund | 28k | $106k | 0% | Jun 2026 |
|
| Geode Capital Management | 19k | $74k | -34% | Jun 2026 |
|
| Shay Capital | 15k | $59k | 4% | Jun 2026 |
|
| BlackRock | 9.7k | $37k | 0% | Jun 2026 |
|
| Vanguard Capital Management | 7.1k | $27k | 0% | Jun 2026 |
|
| Nan Fung Group Holdings | 5.0k | $19k | -83% | Jun 2026 |
|
| Morgan Stanley | 3.2k | $13k | 2% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 3.1k | $12k | 0% | Jun 2026 |
|
| Goss Wealth Management | 2.5k | $9.7k | 100% | Jun 2026 |
|
| Tower Research Capital | 1.7k | $6.6k | 56% | Jun 2026 |
|
| Mercer Global Advisors | 292.00 | $1.1k | 100% | Jun 2026 |
|
| UBS Group | 255.00 | $1.0k | -68% | Jun 2026 |
|
| SBI Securities | 130.00 | $500.994000 | 1200% | Jun 2026 |
|
| Jpmorgan Chase & Co | 42.00 | $165.001200 | 100% | Jun 2026 |
|
| Barclays | 6.00 | $22.999800 | 0% | Jun 2026 |
|
Who sold out of Bolt Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor | Mar 2026 | 43k | $172k |
| Susquehanna International | Mar 2026 | 12k | $47k |
| Vanguard Global Advisers | Mar 2026 | 24.00 | $97.000800 |